TP53 and bladder transitional cell carcinoma: TP53 is one of the most common mutations in BLCA, and BLCA patients with TP53 mutations tend to present with a relatively poorer prognosis and higher grade of pathology than patients without TP53 mutations (Ciccarese et al., 2017).